Abstract
Background: Evolocumab is a potent lipid-lowering drug that decreases plasma levels of low-density lipoprotein cholesterol (LDL-C) by 50-60%. FOURIER ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
